US · Healthcare

Nutranomics Inc (NNRX)

Drug Manufacturers - Specialty & Generic

Nutranomics Inc (NNRX) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NNRX

P/E ratio

18.00

Nutranomics Inc (NNRX) — FAQ

What is NNRX's P/E ratio?

The price-to-earnings (P/E) ratio for Nutranomics Inc (NNRX) is 18.00 (data as of 2026-03-24).

Does Nutranomics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Nutranomics Inc (NNRX). Check the MyAverix Finance app for the latest dividend data.

What sector is Nutranomics Inc in?

Nutranomics Inc (NNRX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is NNRX listed on?

NNRX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)